Improving Glycemic Outcomes in T1D Using an Automated Decision Support Recommender System: Evaluation In Silico and Compared with Physician Recommendations

被引：0
|
作者：
Tyler, Nichole S.
Mosquera-Lopez, Clara M.
Wilson, Leah M.
Resalat, Navid
Dodier, Robert
Branigan, Deborah
Gabo, Virginia
El Youssef, Joseph
Castle, Jessica R.
Jacobs, Peter G.
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1051-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1051-P
引用
收藏
页数：2
相关论文
共 18 条
  • [11] GLYCEMIC IMPROVEMENT IN 1,311 PATIENTS WITH TYPE 1 DIABETES (T1D) USING THE OMNIPOD DASH® INSULIN MANAGEMENT SYSTEM OVER FIRST 90 DAYS OF USE
    Aleppo, G.
    Desalvo, D.
    Lauand, F.
    Huyett, L.
    Jantz, J.
    Chang, A.
    Vienneau, T.
    Ly, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A51 - A51
  • [12] HOSPITALIZED TYPE 1 DIABETES PATIENTS (T1D) WITH COVID-19, WITH AND WITHOUT DIABETIC KETOACIDOSIS (DKA) HAD SIMILAR OUTCOMES USING AN ELECTRONIC GLYCEMIC MANAGEMENT SYTSTEM (EGMS)
    Bode, B.
    Messler, J.
    Booth, R.
    Hebblewhite, H.
    Clarke, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A107 - A107
  • [13] Patient reported outcomes (PROs) using the Lilly/Alkermes inhaled insulin system versus injectable insulin in patients with type 1 diabetes (T1D)
    Hayes, RP
    Muchmore, DB
    Stump, TE
    Silverman, B
    DIABETES, 2005, 54 : A495 - A495
  • [14] Glycemic Improvement in 5,094 Pediatric Patients with Type 1 Diabetes (T1D) Using the Omnipod Insulin Management System over First 90 Days of Use
    Desalvo, Daniel
    Aleppo, Grazia
    Lauand, Felipe
    Huyett, Lauren M., Sr.
    Jantz, Jay
    Chang, Albert
    Vienneau, Todd
    Ly, Trang T.
    DIABETES, 2021, 70
  • [15] EP018/#412 GLYCEMIC OUTCOMES IN PEDIATRIC AND ADULT INDIVDUALS WITH TYPE 1 DIABETES (T1D) DURING MINIMED™ 780G SYSTEM USE WITH THE GUARDIAN™ 4 SENSOR
    Shin, J.
    Bode, B.
    Brazg, R.
    Buckingham, B.
    Carlson, A.
    Kaiserman, K.
    Kipnes, M.
    Liljenquist, D.
    Philis-Tsimikas, A.
    Pihoker, C.
    Pop-Busui, R.
    Reed, J. C.
    Sherr, J.
    Shulman, D.
    Slover, R.
    Thrasher, J.
    Chen, X.
    Cordero, T.
    Rhinehart, A.
    Vella, M.
    Vigersky, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A87 - A88
  • [16] Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)
    Petrovski, Goran
    Al Khalaf, Fawziya
    Campbell, Judith
    Day, Emma
    Almajaly, Douha
    Hussain, Khalid
    Pasha, Maheen
    Umer, Fareeda
    Hamdan, Manar
    Khalifa, Amel
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [17] Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)
    Goran Petrovski
    Fawziya Al Khalaf
    Judith Campbell
    Emma Day
    Douha Almajaly
    Khalid Hussain
    Maheen Pasha
    Fareeda Umer
    Manar Hamdan
    Amel Khalifa
    BMC Endocrine Disorders, 22
  • [18] Glycemic Control Using Recommended Settings in Youth and Adults with Type 1 Diabetes (T1D) - Minimed 780G System with the Calibration-Free Guardian 4 Sensor Results
    Vigersky, Robert A.
    Bode, Bruce W.
    Brazg, Ronald L.
    Buckingham, Bruce A.
    Carlson, Anders L.
    Kaiserman, Kevin B.
    Kipnes, Mark
    Liljenquist, David R.
    Philis-Tsimikas, Athena
    Pihoker, Catherine
    Pop-Busui, Rodica
    Reed, John
    Sherr, Jennifer
    Shulman, Dorothy I.
    Slover, Robert H.
    Thrasher, James
    Chen, Xiaoxiao
    Liu, Margaret
    Cordero, Toni L.
    Vella, Melissa
    Rhinehart, Andrew S.
    Shin, John
    DIABETES, 2022, 71
12